Jump to content

Upsher-Smith Laboratories

From Wikipedia, the free encyclopedia
Upsher-Smith Laboratories
Company typeSubsidiary
IndustryPharmaceuticals
Founded1919; 105 years ago (1919) in Wayzata, Minnesota, U.S.
HeadquartersMaple Grove, Minnesota, U.S.
Key people
Products
Parent
Websitewww.upsher-smith.com

Upsher-Smith Laboratories, LLC is an American pharmaceutical company based in Maple Grove, Minnesota. Founded in 1919, it has been owned by Bora Pharmaceuticals since 2024.

History

[edit]

Founded in 1919 as a maker of digitalis drugs,[3] Upsher-Smith has traditionally focused on the manufacture of generic medications.

In 2017, after owning it for 47 years, the Evenstad family decided to sell most of the firm, the generics business, to Sawai Group Holdings Co., Ltd. [jp], a large publicly traded generics company in Japan that had been seeking entry into the U.S. market.[4] Its non-generic pharmaceutical business, Proximagen, Pairnomix, and MOBĒ, remained with ACOVA, a holding company owned by the Evenstads.

On April 1, 2024, Upsher-Smith Laboratories was acquired by Bora Pharmaceuticals Co., Ltd., considered the largest pharmaceutical manufacturer in Taiwan.[5]

Locations

[edit]

Products

[edit]

Upsher-Smith offers brand and generic pharmaceuticals to treat the following disease states:[7]

References

[edit]
  1. ^ "Taku Nakaoka Named CEO of Upsher-Smith Laboratories".
  2. ^ "Executive Team".
  3. ^ "Upsher-Smith History".
  4. ^ "Sawai Pharmaceutical Completes Acquisition of Upsher-Smith Laboratories Generics Business". May 31, 2017.
  5. ^ "Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith". Upsher-Smith. Retrieved 2024-04-04.
  6. ^ a b c "Locations – Upsher-Smith". Upsher-Smith Laboratories, LLC. Retrieved 2022-06-21.
  7. ^ "Upsher-Smith Products".